Ulf Björklund

Président chez REDWOOD PHARMA AB

Profil

Ulf Björklund currently works at Ub-Consulting AB, as Chief Executive Officer & Director, Redwood Pharma AB, as Chairman & Chief Medical Officer from 2023, Lipum AB, as Chairman from 2016, Stayble Therapeutics AB, as Chairman from 2021, and Nimutan AB, as Director from 2019.
Mr. Björklund also formerly worked at Aprea Therapeutics AB, as Chief Executive Officer from 2010 to 2016, OxyPharma AB, as Chief Executive Officer from 2002 to 2010, Wntresearch AB, as Chairman from 2018 to 2019, ProNoxis AB, as Director, TikoMed AB, as Director, Aptahem AB, as Director-Clinical Research, Annexin Pharmaceuticals AB, as Director, and Synartro AB, as Chief Scientific Officer.
Mr. Björklund received his graduate degree from the University of Uppsala.

Postes actifs de Ulf Björklund

Sociétés	Poste	Début
REDWOOD PHARMA AB	Président	01/01/2023
LIPUM AB	Président	01/01/2016
NIMUTAN AB (PUBL)	Directeur/Membre du Conseil	01/05/2019
STAYBLE THERAPEUTICS AB	Président	02/06/2021
Ub-Consulting AB	Directeur Général	-

Anciens postes connus de Ulf Björklund

Sociétés	Poste	Fin
Aptahem AB	Directeur des opérations	14/01/2022
WNTRESEARCH AB	Président	01/06/2019
Aprea Therapeutics AB	Directeur Général	01/04/2016
OxyPharma AB	Directeur Général	01/10/2010
░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░	-

Formation de Ulf Björklund

University of Uppsala

Graduate Degree